| Product NDC: | 52670-566 |
| Proprietary Name: | Choline C 11 |
| Non Proprietary Name: | choline C 11 |
| Active Ingredient(s): | 33.1 mCi/mL & nbsp; choline C 11 |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52670-566 |
| Labeler Name: | Mayo Clinic |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA203155 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120912 |
| Package NDC: | 52670-566-30 |
| Package Description: | 30 mL in 1 VIAL, SINGLE-DOSE (52670-566-30) |
| NDC Code | 52670-566-30 |
| Proprietary Name | Choline C 11 |
| Package Description | 30 mL in 1 VIAL, SINGLE-DOSE (52670-566-30) |
| Product NDC | 52670-566 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | choline C 11 |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120912 |
| Marketing Category Name | NDA |
| Labeler Name | Mayo Clinic |
| Substance Name | CHOLINE C-11 |
| Strength Number | 33.1 |
| Strength Unit | mCi/mL |
| Pharmaceutical Classes |